Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: May 25, 2018
Open Peer Review Period: May 31, 2018 - Jun 14, 2018
Date Accepted: Nov 2, 2018
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

Rice B, Boulle A, Schwarcz S, Shroufi A, Rutherford G, Hargreaves J

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

JMIR Public Health Surveill 2019;5(1):e11136

DOI: 10.2196/11136

PMID: 30892272

PMCID: 6446153

The continuing value of CD4 cell count monitoring to differential HIV care and surveillance

  • Brian Rice; 
  • Andrew Boulle; 
  • Sandra Schwarcz; 
  • Amir Shroufi; 
  • George Rutherford; 
  • James Hargreaves

ABSTRACT

The move towards the universal provision of antiretroviral therapy, and the expansion of HIV viral load monitoring, calls into question the ongoing value of CD4 cell count testing and monitoring. We highlight the role CD4 monitoring continues to have in guiding clinical decisions and in measuring and evaluating the epidemiology of HIV. To end the HIV/AIDS epidemic we require strategic information, which includes CD4 cell counts, to make informed clinical decisions and to effectively monitor key surveillance indicators.


 Citation

Please cite as:

Rice B, Boulle A, Schwarcz S, Shroufi A, Rutherford G, Hargreaves J

The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance

JMIR Public Health Surveill 2019;5(1):e11136

DOI: 10.2196/11136

PMID: 30892272

PMCID: 6446153

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.